Subscribe to this column
Don S. Dizon, MD, FACP, FASCO
Don S. Dizon, MD, FACP, FASCO, is a professor of medicine and professor of surgery at Brown University, director of the Pelvic Malignancies Program and Hematology-Oncology Outpatient Clinics at Lifespan Cancer Institute, and director of Medical Oncology and the Sexual Health First Responders Clinic at Rhode Island Hospital. He also serves as the head of community outreach and engagement of the Legorreta Cancer Center at Brown University. Dr. Dizon has served as past chair of ASCO's Social Media Working Group and the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for The Oncologist and a section editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the JCO Oncology Practice Editorial Board, and editor in chief of the ASCO Educational Book. Follow Dr. Dizon across social media channels @drdonsdizon.
Dec 27, 2011
Around this time each year I find myself thinking about patients usually—and especially those that have passed away. I wonder how their families are coping, how their children are, and whether each day has gotten easier. I think about how my patients died—and whether or not I did enough to ensure...
Dec 06, 2011
Every once in a while I get an opportunity to speak at a meeting in which oncologists are not the primary audience. Of course, it is always to speak on either gynecologic- or breast-cancer-specific issues, but I always welcome the opportunity to educate a non-oncology audience about what we can do...
Oct 29, 2011
I was recently asked to comment on a study that sought to address the risk of ovarian cancer in women who undergo in vitro...
Oct 22, 2011
I was recently interviewed about breast cancer in young women, spurred by the recent disclosure that Giuliana Rancic, of E! Entertainment News, was diagnosed with breast cancer. It struck me as...
Oct 06, 2011
I am currently sitting with colleagues from across the country as we plan the 2012 Program, an honor and yet a daunting task! Searching pubmed, vetting potential speakers, and keeping abreast on office and business matters, I rely heavily on my laptop and web access, and dating back to 1986, I have...
Sep 24, 2011
I have followed with interest the exciting progress being made across oncology--progress in melanoma with the anti-CTLA agent iplimumab and the BRAF inhibitor,...
Latest Blogs